anti-CRH immunotoxin PFU 83 (IgG)-RTA

CAT#: AGTO-L007R

This immunotoxin was achieved by conjugating/fusing the Anti-CRH monoclonal antibody to ricin toxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to CRF neurons cells. Then the ricin A chain is incorporated into the cell by receptor-mediated endocytosis, blocking ribosomal protein synthesis and ultimately leading to cell death. It was designed for treatment of Anorexia nervosa.

Gene Expression
Figure 1 RNA cell line category: Cell line enhanced (SuSa)

Specifications

  • Host Species
  • Rat
  • Species Reactivity
  • Human
  • Clone
  • PFU 83
  • Molecule Class
  • L kappa; IgG2a-RTA
  • Toxin Description
  • Ricin consist of two polypeptide chains, A and B, linked by means of disulfide bridge(s). Cytotoxicity is associated with the A chain and its 15 inhibition of protein synthesis in nucleated cells. The B chain is essentially a delivery vehicle for the A chain. The B chain recognizes polysaccharide units at the surface of cells and creates a high affinity interaction with such units. Once the B chain binds with polysaccharide units at 20" the celL surface, the A chain is incorporated into the cell, blocking ribosomal protein synthesis and ultimately leading tocell death. The use of ricin A chain is preferred in this invention.
  • Applications
  • This product is suitable for use in cytotoxicity assay, functional assay and immunotherapy.
  • Related Disease
  • Anorexia nervosa

Target

  • Alternative Names
  • CRH; corticotropin releasing hormone; CRF; CRH1; corticoliberin; corticotropin-releasing factor; Anorexia nervosa; Deglycosylated ricin A chain; Ricin A chain; Ricin A; Ricin; RTA; RT; RA; dgRTA; dgRA; dgA
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AGTO-L007R. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Benchmark for Specificity
This antibody has established a standard for specificity in our laboratory. There are no cross-reactions, and the results are clear-it's ideal for our needs.
Breast cancer biomarkers at key points during disease progression
User-friendly
The antibody is easy to use and effective in a wide range of applications. Preparation and use are both uncomplicated.
Breast cancer biomarkers at key points during disease progression
Excellent Support
Customer care was extremely prompt and provided effective answers to all of our technical questions. This type of support is quite beneficial.

Q&As

  1. Do I need to block non-specific binding sites before using the antibody?

    A: Yes, blocking non-specific binding sites is essential. We recommend using a blocking solution like 5% BSA or non-fat milk in PBS for best results.

  2. The signal is weak; what could be the problem?

    A: Weak signal can be due to insufficient antibody concentration, inadequate incubation time, or poor antigen retrieval. Increasing primary antibody concentration or extending incubation times can help.

  3. Does this antibody show cross-reactivity with other proteins?

    A: Our antibody is validated for high specificity and shows minimal cross-reactivity with other proteins, making it ideal for precise experimental outcomes.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Related Diseases

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "Clone PFU 83"

See other products for "CRH"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
MOB-2504z Mouse Anti-CRH Recombinant Antibody (clone 8F1) WB, ELISA, IP Mouse IgG2a, κ
MOB-1700MZ Recombinant Mouse Anti-Human CRH Antibody (clone 5I0) ELISA, IHC-Fr, IHC-P Mouse antibody
CAT Product Name Application Type
BRD-0135MZ Chicken Anti-CRH Polyclonal IgY WB Chicken antibody
CAT Product Name Application Type
VS-0525-XY1670 Anti-CRH Immunohistochemistry Kit IHC
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare